Find latest Myeloma videos · 600+ videos
2024 ASCO® Annual Meeting Insights Hub
R

ASCO® 2024 Insights: "Real World Outcomes of Pts With MM Who Received Bispecific Antibodies After CAR-T"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Radhika Bansal
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Radhika Bansal
133 views
June 19, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Related Videos

21:06

ASH 2024 Summary: Myeloma Highlights and Impact on Practice

2024 ASH Annual Meeting Insights Hub

H. Hashmi

1.5K views
28:15

ASH 2024 Review: Key Multiple Myeloma Abstracts

Cleveland Clinic Taussig Cancer Institute

N. Callander

518 views
19:28

ASH 2024 Summary: Multiple Myeloma Highlights and Clinical Implicati…

2024 ASH Annual Meeting Insights Hub

S. Al Hadidi

499 views
15:35

Multiple Myeloma: Not as Simple as "CRAB" Anymore

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

R. Banerjee

810 views
13:28

Debate: Using BCMA CAR-T in Early vs Late Line R/R MM Treatment

Louisville Hematology Highlights

K. Patel, S. Usmani

209 views
26:59

Multiple Myeloma: A Journey From Pharaoh's Times to 2024

Houston Methodist

S. Ganguly

393 views
08:58

Transition of Care for Bispecific Antibodies in RRMM: Closing the Ga…

Cleveland Clinic Taussig Cancer Institute

S. Mazzoni

137 views
11:20

Real-World Characteristics and Outcomes in Patients With RRMM Receiv…

Adeel Khan

153 views
11:17

CAR-T Strategies and Clinical Considerations for R/R MM

Moffitt Cancer Center

K. Patel

172 views
45:27

Cellular Therapy in 2024: What, Why, When, Who… and Where Are We Goi…

University of Colorado Department of Medicine

J. Gutman

536 views
29:37

Making Sense in R/R Myeloma: Guideline-Based Current Approaches

Saurabh Chhabra

200 views
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

605 views
06:06

The Future of NDMM Treatment: Ongoing Trials and Key ASH 2024 Oral A…

University of Miami Sylvester Comprehensive Cancer Center

O. Landgren

102 views
17:52

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Indy Hematology Review

K. Anderson

1.3K views
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

734 views
16:55

Anti-BMCA Bispecific Antibodies - Independent Symposium at the 10th …

Springer Healthcare IME

S. Usmani

228 views
05:55

ASH 2024 Insights: Efficacy of Anti-BCMA CAR-T in Myeloma Patients P…

2024 ASH Annual Meeting Insights Hub

J. Waldschmidt

158 views
30:09

Expert Roundtable: Future Directions in Managing NDMM - MRD, CAR-T, …

MyCancerHaven

R. Vij, P. Kapoor, M. Alsina, S. Mailankody, A. Nooka, S. Tuchman

129 views
24:35

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstr…

2024 ASCO® Annual Meeting Insights Hub

H. Hashmi

662 views
09:07

CARTITUDE-4 Update: OS With Cilta-Cel vs. SOC in Len-Refractory Mult…

Maria-Victoria Mateos

251 views
AUTOPLAY